Cannabinoid patch and method for cannabis transdermal delivery US 6328992 B1 - Publication Date December 11, 2001.
Referenced by GW Pharma, Mary's Medicinal's (Colorado Springs), Axim BioTech.
The information I am looking for is how the VDRM patent that no one has posted in the iBox or Stickies, with unproven claims as stated below, separates itself above the existing patent linked below.
Quote:CBD's is known for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis.
Quote:ViaDerma sees the use of CBD's along with our Proprietary transdermal delivery system for the treatment and continuing studies looks very promising and demonstrates efficacy in terms of treating several unrelated diseases. "We are enthusiastic about the results we have achieved to date in terms of the anecdotal feedback we have received from the medical community," said Dr. Christopher Otiko, ViaDerma's founder and CEO.